NCT01153750View on ClinicalTrials.gov

Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct

Interventions

DRUG

Glivec

Trial Locations (8)

16816

Ruppiner Kliniken GmbH, Neuruppin

20249

Onkologische Schwerpunktpraxis Eppendorf, Hamburg

21680

Praxisgemeinschaft Dr. Hancken und Partner, Stade

24105

University Hospital Schleswig-Holstein, Campus Kiel, Kiel

36130

Staedtisches Klinikum Magdeburg, Magdeburg

55131

Johannes-Gutenberg-Universität Mainz, Medical Department I, Mainz

60488

Krankenhaus Nordwest, Frankfurt am Main

01307

University Hospital, Dresden

All Listed Sponsors

lead

University Hospital Dresden

OTHER

NCT01153750 - Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct | Biotech Hunter | Biotech Hunter